Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism

被引：117

作者：

Hayakawa, Kazuhide ^{[1
]}

Mishima, Kenichi ^{[1
]}

Nozako, Masanori ^{[1
]}

Hazekawa, Mai ^{[1
]}

Mishima, Shohei ^{[1
]}

Fujioka, Masayuki ^{[1
]}

Orito, Kensuke ^{[3
]}

Egashira, Nobuaki ^{[1
]}

Iwasaki, Katsunori ^{[1
,2
]}

Fujiwara, Michihiro ^{[1
,2
]}

机构：

[1] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Fukuoka 8140180, Japan

[2] Fukuoka Univ, Adv Mat Inst, Fukuoka 8140180, Japan

[3] Azabu Univ, Sch Vet Med, Dept Vet Pharmacol, Kanagawa, Japan

来源：

STROKE | 2008年 / 39卷 / 03期

关键词：

cerebral ischemia; high-mobility group box1; minocycline; microglia; neuroprotection;

D O I：

10.1161/STROKEAHA.107.495820

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Background and Purpose - Minocycline, a semisynthetic tetracycline antibiotic, has been reported to ameliorate brain injury and inhibit microglial activation after focal cerebral ischemia. However, the cerebroprotective mechanism of minocycline remains unclear. In the present study, we investigated that mechanism of minocycline in a murine model of 4-hour middle cerebral artery (MCA) occlusion. Methods - One day after 4-hour MCA occlusion, minocycline was administered intraperitoneally for 14 days. Neurologic scores were measured 1, 7, and 14 days after cerebral ischemia. Motor coordination was evaluated at 14 days by the rota-rod test at 10 rpm. Activated microglia and high-mobility group box1 (HMGB1), a cytokine-like mediator, were also evaluated by immunostaining and Western blotting. In addition, terminal deoxynucleotidyl transferase - mediated dUTP nick end-labeling immunostaining was carried out 14 days after cerebral ischemia. Results - Repeated treatment with minocycline (1, 5, and 10 mg/kg) for 14 days improved neurologic score, motor coordination on the rota-rod test, and survival in a dose-dependent manner. Minocycline decreased the expression of Iba1, a marker of activated microglia, as assessed by both immunostaining and Western blotting. Moreover, minocycline decreased the activation of microglia expressing HMGB1 within the brain and also decreased both brain and plasma HMGB1 levels. Additionally, minocycline significantly decreased the number of terminal deoxynucleotidyl transferase mediated dUTP nick end-labeling - positive cells and prevented ischemic brain atrophy 14 days after cerebral ischemia. Conclusions - Our results suggest that minocycline inhibits activated microglia expressing HMGB1 and decreases neurologic impairment induced by cerebral ischemia. Minocycline will have a palliative action and open new therapeutic possibilities for treatment of postischemic injury via an HMGB1-inhibiting mechanism.

引用

页码：951 / 958

页数：8

共 37 条

[1] Cutting edge: HMG-1 as a mediator of acute lung inflammation [J].

Abraham, E ;

Arcaroli, J ;

Carmody, A ;

Wang, HC ;

Tracey, KJ .

JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :2950-2954

[2] HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion [J].

Agnello, D ;

Wang, HC ;

Yang, H ;

Tracey, KJ ;

Ghezzi, P .

CYTOKINE, 2002, 18 (04) :231-236

[3] Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury [J].

Arvin, KL ;

Han, BH ;

Du, YS ;

Lin, SZ ;

Paul, SM ;

Holtzman, DM .

ANNALS OF NEUROLOGY, 2002, 52 (01) :54-61

[4] Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].

Banati, RB ;

Daniel, SE ;

Blunt, SB .

MOVEMENT DISORDERS, 1998, 13 (02) :221-227

[5] MICROGLIAL-PRODUCED NITRIC-OXIDE AND REACTIVE NITROGEN-OXIDES MEDIATE NEURONAL CELL-DEATH [J].

BOJE, KM ;

ARORA, PK .

BRAIN RESEARCH, 1992, 587 (02) :250-256

[6] Antiinflammatory effects of estrogen on microglial activation [J].

Bruce-Keller, AJ ;

Keeling, JL ;

Keller, JN ;

Huang, FF ;

Camondola, S ;

Mattson, MP .

ENDOCRINOLOGY, 2000, 141 (10) :3646-3656

[7]

Bustin M, 1999, MOL CELL BIOL, V19, P5237

[8] Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease [J].

Chen, M ;

Ona, VO ;

Li, MW ;

Ferrante, RJ ;

Fink, KB ;

Zhu, S ;

Bian, J ;

Guo, L ;

Farrell, LA ;

Hersch, SM ;

Hobbs, W ;

Vonsattel, JP ;

Cha, JHJ ;

Friedlander, RM .

NATURE MEDICINE, 2000, 6 (07) :797-+

[9] PRODUCTION OF SUPEROXIDE ANIONS BY A CNS MACROPHAGE, THE MICROGLIA [J].

COLTON, CA ;

GILBERT, DL .

FEBS LETTERS, 1987, 223 (02) :284-288

[10] Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice [J].

Egashira, N ;

Iwasaki, K ;

Takashima, A ;

Watanabe, T ;

Kawabe, H ;

Matsuda, T ;

Mishima, K ;

Chidori, S ;

Nishimura, R ;

Fujiwara, M .

BRAIN RESEARCH, 2005, 1059 (01) :7-12

← 1 2 3 4 →